Skip to main content
. Author manuscript; available in PMC: 2016 Jul 27.
Published in final edited form as: JAMA Neurol. 2013 Dec;70(12):1512–1519. doi: 10.1001/jamaneurol.2013.4013

Figure 4. Relationship Between Neurodegenerative Abnormalities and Pittsburgh Compound B (PiB) Status in the Berkley Aging Cohort (BAC) Cognitively Normal (NC) Cases.

Figure 4

The percentage of individuals with 0, 1, or more than 1 abnormal neurodegenerative biomarker stratified by PiB status (PiB+ or PiB−).